Case Report
Copyright ©The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Clin Cases. Mar 26, 2024; 12(9): 1698-1703
Published online Mar 26, 2024. doi: 10.12998/wjcc.v12.i9.1698
Unexplained fetal tachycardia: A case report
Hui Wang, Run-Zi Duan, Xin-Jiu Bai, Bing-Ting Zhang, Jie Wang, Wen-Xia Song
Hui Wang, Department of Nutrition, Changzhi Maternal and Child Health Care Hospital Affiliated to Changzhi Medical College, Changzhi 046000, Shanxi Province, China
Run-Zi Duan, Bing-Ting Zhang, Jie Wang, Department of Obstetrics, Changzhi Maternal and Child Health Care Hospital Affiliated to Changzhi Medical College, Changzhi 046000, Shanxi Province, China
Xin-Jiu Bai, Department of Gynaecology, Changzhi Maternal and Child Health Care Hospital Affiliated to Changzhi Medical College, Changzhi 046000, Shanxi Province, China
Wen-Xia Song, Department of Medical Genetic, Changzhi Maternal and Child Health Care Hospital Affiliated to Changzhi Medical College, Changzhi 046011, Shanxi Province, China
Co-first authors: Hui Wang and Run-Zi Duan.
Author contributions: Wang H and Duan RZ contributed equally to this work; Wang H and Duan RZ collected cases, recorded data and write review; Bai XJ processed the image; Zhang BT followed up patients; Wang J reeded and searched for paper; Song WX planed overall, wrote and modified review. All authors have read and approve the final manuscript.
Informed consent statement: Informed written consent was obtained from the patient for publication of this report and any accompanying images.
Conflict-of-interest statement: The authors declare no conflict of interest.
CARE Checklist (2016) statement: The authors have read the CARE Checklist (2016), and the manuscript was prepared and revised according to the CARE Checklist (2016).
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Wen-Xia Song, MD, Chief Physician, Department of Medical Genetic, Changzhi Maternal and Child Health Care Hospital Affiliated to Changzhi Medical College, No. 48 Weiyuanmen Middle Road, Luzhou District, Changzhi 046011, Shanxi Province, China. songwenxia.love@163.com
Received: January 6, 2024
Peer-review started: January 6, 2024
First decision: January 17, 2024
Revised: February 22, 2024
Accepted: February 28, 2024
Article in press: February 28, 2024
Published online: March 26, 2024
Processing time: 79 Days and 1 Hours
Core Tip

Core Tip: Clinical manifestations and obstetric management of this case demonstrated that the abnormal fetal heart rate (FHR) of unknown etiology could be transiently controlled by varying doses of sotalol hydrochloride tablets. However, not all pregnant women experience favorable outcomes. Therefore, the treatment and obstetric management strategies for unexplained FHR abnormalities need investigation.